Cargando…

I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life

Detalles Bibliográficos
Autores principales: Riccio, V., Riccio, I., Gimigliano, F., Riccardi, D., Riccardi, G., Gimigliano, R., Politano, L, Nigro, G., Duport, G., Rideau, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235836/
_version_ 1782218644071120896
author Riccio, V.
Riccio, I.
Gimigliano, F.
Riccardi, D.
Riccardi, G.
Gimigliano, R.
Politano, L
Nigro, G.
Duport, G.
Rideau, Y.
author_facet Riccio, V.
Riccio, I.
Gimigliano, F.
Riccardi, D.
Riccardi, G.
Gimigliano, R.
Politano, L
Nigro, G.
Duport, G.
Rideau, Y.
author_sort Riccio, V.
collection PubMed
description
format Online
Article
Text
id pubmed-3235836
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Pacini Editore SpA
record_format MEDLINE/PubMed
spelling pubmed-32358362012-01-20 I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life Riccio, V. Riccio, I. Gimigliano, F. Riccardi, D. Riccardi, G. Gimigliano, R. Politano, L Nigro, G. Duport, G. Rideau, Y. Acta Myol Lectures by Invited Speakers Pacini Editore SpA 2011-10 /pmc/articles/PMC3235836/ Text en The journal and the individual contributions contained in it are protected by the copyright of Gaetano Conte Academy, Naples, Italy http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Lectures by Invited Speakers
Riccio, V.
Riccio, I.
Gimigliano, F.
Riccardi, D.
Riccardi, G.
Gimigliano, R.
Politano, L
Nigro, G.
Duport, G.
Rideau, Y.
I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
title I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
title_full I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
title_fullStr I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
title_full_unstemmed I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
title_short I-21 Current therapeutic guidelines in Duchenne Muscular Dystrophy to prolong life
title_sort i-21 current therapeutic guidelines in duchenne muscular dystrophy to prolong life
topic Lectures by Invited Speakers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235836/
work_keys_str_mv AT ricciov i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT riccioi i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT gimiglianof i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT riccardid i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT riccardig i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT gimiglianor i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT politanol i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT nigrog i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT duportg i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife
AT rideauy i21currenttherapeuticguidelinesinduchennemusculardystrophytoprolonglife